Voices from the Doximity Network
Paul A Greenberger, MD
Mar 5, 2023
Manav Singla, MD
Mar 5, 2023 Link to From AAAAI 2023: The Constantly Evolving Story of Food Allergies
Guru P Sonpavde, MD
Feb 27, 2023 Link to ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advances
Julie R Gralow, MD
Feb 27, 2023 Link to ASCO GU 2023 Highlights With Dr. Julie Gralow
JJ Haijing Zhang, MD
Feb 27, 2023 Link to Imperative Paradigm Shifts at ASCO GU 2023: Health Equity, De-escalation of Surgery and the De-escalation of Manels
Hardeep Singh Phull, MD
Feb 6, 2023 Link to Medical Conferences Are an Opportunity To Nourish Mentorships
Alyssa Maria Parian, MD and 1 other
Jan 30, 2023 Link to A Review of "Controversies in IBD: Shark Tank Edition"
Jan 30, 2023 Link to Milestones and New Research from ASCO GI 2023
James Friebe
Jan 9, 2023 Link to Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congress
Lynne Lederman, PhD
Dec 19, 2022 Link to First-in-Class Agent Addresses Unmet Need in Myeloma
Dec 19, 2022 Link to Questioning the Status Quo for Children with ALL at ASH
Dec 19, 2022 Link to Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrence
Dec 19, 2022 Link to Screening for Breast Cancer by Genetics or Imaging in Community Settings
Dec 19, 2022 Link to How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship
Stephen Douglas Smith, MD
Dec 19, 2022 Link to Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions
Samuel Kareff, MD MPH
Dec 19, 2022 Link to Benefits of Virtual Conference Attendance: ASH 2022 Edition
Hayder Saeed, MD
Dec 19, 2022 Link to Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?
Suzanne Baga, MA, RRT
Dec 19, 2022 Link to Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani
Heather Moore, CPP, PharmD and 1 other
Dec 19, 2022 Link to Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer
Kimberly J. Van Zee, MS, MD, FACS
Dec 18, 2022 Link to Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?
David Rimm MD-PhD
Dec 18, 2022 Link to HER2-Low, A Separate Entity?
Katharine Yao, MD
Dec 18, 2022 Link to Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations